Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis-Reference-Cited by-同舟云学术

Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis

Published:2007-07-28 Issue:3 Volume:28 Page:225-231
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Iwai Kaori,Ishii Masaru,Ohshima Shiro,Miyatake Kunio,Saeki Yukihiko

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-007-0424-4.pdf

Reference34 articles.

1. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504–1508

2. Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638–649

3. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342

4. Johnston CC, Hui SL, Witt RM, Appledorn R, Baker RS, Longcope C (1985) Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab 61:905–911

5. Slemenda C, Hui SL, Longcope C, Johnston CC (1987) Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest 80:261–269

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrin α2 is an early marker for osteoclast differentiation that contributes to key steps in osteoclastogenesis;Frontiers in Cell and Developmental Biology;2024-08-15

2. Receptor activator of nuclear factor-kappa B is enriched in CD9-positive extracellular vesicles released by osteoclasts;Extracellular Vesicles and Circulating Nucleic Acids;2023

3. CD9 induces cellular senescence and aggravates atherosclerotic plaque formation;Cell Death & Differentiation;2020-04-28

4. OC‐STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up‐regulation of permissive fusogen CD9;The FASEB Journal;2018-03-13

5. Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis;The Korean Journal of Internal Medicine;2018-03-01